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Abstract
Fatigue is increasingly recognized as a significant problem in patients with chronic
inflammatory and autoimmune diseases. In celiac disease, a chronic immune-mediated
disease triggered by dietary gluten, conflicting opinions exist regarding both the size
of the problem and the effect of a gluten-free diet (GFD) on fatigue. We reviewed the
existing literature regarding fatigue in celiac disease. We conducted a systematic
search in the Embase, Ovid Medline, and Cochrane databases using subject terms
from controlled vocabularies. Articles were reviewed based on language, type of arti-
cle, title, and abstract or full text. Eighteen articles were finally selected for review.
Fatigue was significantly greater in patients with celiac disease compared to healthy
control subjects. Fatigue prevalence ranged from 8 to 100%. Fatigue severity was
assessed in six studies. The fatigue visual analogue scale was the most frequently used
fatigue instrument with scores from 57 to 79 prior to starting a GFD and from 39 to
59 in patients on a GFD. Seven studies investigated the effect of a GFD on fatigue,
including five studies that reported less fatigue while on the diet and two studies that
showed no significant difference. This review concludes that fatigue is a substantial
complaint in patients with celiac disease. A GFD seems to reduce fatigue, but existing
data are limited.
Introduction
Fatigue can be defined as “an overwhelming sense of tiredness,
lack of energy, and feeling of exhaustion”1 and can interfere with
physical and mental work, affecting the quality of life of many
patients.2,3 Fatigue has increasingly been recognized as a sub-
stantial complaint in patients with chronic inflammatory and
autoimmune diseases, including inflammatory bowel disease, as
well as cancer and neurodegenerative diseases.4–6
The pathogenesis of fatigue is only partially understood. A
conceptual model for understanding fatigue is the “sickness
behavior response,” an evolutionarily preserved survival-
enhancing strategy in humans and animals that occurs during
states of infection or damage.7,8 The sickness behavior response
is characterized by several phenomena, such as decreased activ-
ity, tiredness, fatigue, depression, social withdrawal, and loss of
thirst and hunger. The response is triggered by pro-inflammatory
cytokines, especially interleukin-1β. In inflammatory states, this
cytokine is rapidly produced and released by innate immune cells
and transported into the brain, where it binds to specific receptors
on cerebral neurons and induces sickness behavior.2 Several
other factors are known to influence fatigue, including depres-
sion, pain, and sleep disturbances.9
Celiac disease is a chronic, immune-mediated, small intes-
tinal enteropathy that affects approximately 1% of the North
European population.10 The disease is caused by exposure to die-
tary gluten in genetically predisposed individuals and is charac-
terized by chronic intestinal inflammation that varies from a
barely increased number of intraepithelial lymphocytes to muco-
sal atrophy.11 The clinical presentation of celiac disease varies
from the classical malabsorption symptoms with diarrhea, weight
loss, and abdominal pain to constipation, reflux, and various neu-
rological symptoms.11,12 Diagnosis is based on histopathological
findings in duodenal biopsies, in addition to positive serology,
elevated serum levels of tissue transglutaminase IgA antibodies,
specific endomysial antibodies, and/or deamidated gliadin pep-
tide antibodies, either IgA or IgG isotype.10 The only well-
established treatment for celiac disease is to avoid gluten in the
diet, which in the majority of patients leads to normalization of
the small intestinal mucosa and reduced blood levels or loss of
specific plasma antibodies.
The quality of life in patients suffering from celiac disease
is reduced and is at least partly linked to the dietary restrictions
with regard to a gluten-free diet (GFD).13,14 Although existing
data are scarce, the chronic inflammatory nature of the disease
implies that fatigue constitutes a significant problem in celiac dis-
ease. Clinical experience and findings from previous studies indi-
cate that, in some patients, fatigue may be the presenting and
single symptom of celiac disease,15,16 and in our clinical
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experience, fatigue is not infrequently perceived as disabling in
untreated patients. It is generally assumed that most celiac
disease-related symptoms disappear when a GFD has been imple-
mented, but whether this also applies to fatigue is unclear.
The aim of this review was to evaluate the existing litera-
ture regarding fatigue in patients with celiac disease to elucidate
fatigue prevalence, severity, and response to GFD.
Methods
We conducted a systematic literature search on 27 June 2017
using the Embase, Ovid Medline, and Cochrane Library data-
bases. We used subject terms from controlled vocabularies
Emtree and MeSH: “celiac disease, celiac sprue, gluten enterop-
athy, gluten sensitive enteropathy, non tropical sprue, gluten
hypersensitivity, gluten sensitivity, duodenal atrophy, fatigue,
tiredness” and combinations thereof.
A total of 265 articles were considered for inclusion in this
review. Non-English language publications were excluded.
Abstracts, case reports, and review articles not including original
data analysis were also omitted. A total of 229 papers were
excluded based on the title, language, or type of article, whereas
17 were excluded based on their abstracts or full text. One arti-
cle17 was excluded to avoid confounding because it presented the
same data material as another18. Thus, 18 articles were finally
included in this review.
Results
Articles included in the review are shown in Table 1.
Study designs. Of the 18 included studies, only one was
multicenter, randomized, double-blind, and placebo-controlled.19
Eleven of the studies were prospective. Three studies were non-
randomized controlled,20–22 and seven were uncontrolled obser-
vational studies.23–29 Seven trials were retrospective in
design.14,18,30–34 Six of the studies were longitudinal, with a
follow-up period from 3 months to 15 years.19,23–26,28
Fatigue instruments. In six studies, a specific instrument
to measure fatigue was used,14,19–21,23,24 and the remaining stud-
ies dichotomized fatigue into questions of yes or no. Three stud-
ies used the fatigue visual analogue scale (fVAS),20,21,24 whereas
the daily fatigue impact scale (D-FIS),23 fatigue severity scale
(FSS),20 Gieβener symptom check list (GBB-24),14 fibromyalgia
impact questionnaire (FIQ),24 chronic fatigue syndrome-
questionnaire (CFS-Q),20 and celiac disease patient reported out-
come (CeD PRO)19 were all applied in one study each.
Validated generic fatigue instruments. The fVAS is a
single-item scale consisting of a horizontal line with vertical
anchors, usually 100 mm. The wording on the left end of the line
(0 mm) is “no fatigue,” and on the right end, it is (100 mm)
“fatigue as bad as it can be.” The patient puts a mark on the hori-
zontal line to describe the degree of fatigue in the prior week.
The score ranges from 0 to 100 mm (0–10 cm).35 The scale is
sensitive to change in fatigue.36 Clinically relevant fatigue has
been defined as fVAS scores ≥50 mm,5,37 although one study
used fVAS scores ≥20 mm as a cut-off for significant fatigue.38
The D-FIS is an eight-item scale designed to capture the
daily impact of fatigue on health-related quality of life.39 Cogni-
tive, psychosocial, and physical symptoms are addressed. Each
item is rated on a 5-point scale ranging from 0 (no problem) to
4 (extreme problem). The added scores represent the D-FIS
score, ranging from 0 to 32, with 12 as the cut-off for significant
fatigue.40
The FSS aims to evaluate and quantify fatigue associated
with chronic disease.41 The questionnaire includes nine questions
rated from 1 to 7. The FSS score is usually reported as the mean
score of the nine questions, ranging from 1 to 7, or as the sum of
all the rated items, ranging from 9 to 63. Significant fatigue has
been defined as a mean FSS score > 4.42
Disease-specific fatigue instruments. The FIQ is an
instrument developed to assess the current health status of
women with fibromyalgia syndrome, including fatigue. Fatigue is
scored in a similar way as on the fVAS; patients are asked to put
a mark on a 10-cm horizontal line to show how tired they felt in
the prior week. The total FIQ score ranges from 0 to 100 and
summarizes the scores from all 10 items: fatigue, stiffness, anxi-
ety, depression, pain, physical impairment, feel good, work
missed, do work, and rested.43
The CFS-Q has not been validated but was developed for
a study that compared chronic “postviral” fatigue with neuromus-
cular and affective disorders. The questionnaire consists of eight
items addressing physical fatigue and five items addressing men-
tal fatigue. Each item is scored from 0 to 2, giving a total score
from 0 to 26.44
Other fatigue instruments. The CeD PRO Non-GI
domain evaluates tiredness combined with headache but does not
evaluate fatigue separately. The score ranges from 0 to 10 points,
with a higher score indicating greater symptom severity.19 The
GBB-24 is a check list that assesses bodily symptoms in four
subscales, including fatigue.45
In two studies, a combination of fatigue instruments was
used: fVAS, CFS-Q, and FSS in one study,20 whereas another
study used the fVAS and FIQ.24
Fatigue prevalence. Fourteen studies reported the preva-
lence of fatigue in celiac disease, ranging from 8 to 100% at the
time of diagnosis, with a mean of 52% and median of
52.5%.18,19,22,24–34
Fatigue severity. Six studies investigated the severity of
fatigue in patients with celiac disease.14,19–21,23,24 The fVAS was
the most frequently used instrument to measure fatigue and was
used in three studies.20,21,24 The fVAS scores reported among
celiac patients before GFD in these studies ranged from 57 to
79 (mean 66). In celiac patients who were on a GFD, the
reported fVAS scores ranged from 39 to 59 (mean 51).20,21,24
Two of the studies reported fVAS scores in patients who had
been on the diet for at least a year (patients on annual control for
their celiac disease).20,21 The last study presented fVAS scores at
diagnosis and after 1 year on a GFD.24 In the controlled studies,
mean fVAS scores were significantly higher in celiac disease
patients (57–61; mean 59)20,21 than in healthy control subjects
(HCS) (34–44; mean 39).20,21 The FSS scores were also
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Table 1 Articles included in the review, sorted according to study design and year of publication
Author, year Primary end-point Study design
No. of
patients (HCS) Fatigue instrument Fatigue-related findings
Multicenter randomized controlled study
Leffler et al.,
201519
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130 (80) fVAS, CFS-Q, FSS Significantly more fatigue
in patients with celiac
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51 D-FIS Significantly worse
fatigue D-FIS scores in
untreated celiac
patients. Fatigue and
quality of life inversely
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Table 1 (Continued)
Author, year Primary end-point Study design
No. of
patients (HCS) Fatigue instrument Fatigue-related findings
correlated. Less













12 Yes/no 46% of celiac disease
patients had
tiredness/lethargy,











































Retrospective cross-sectional, mail studies
Pulido et al.,
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328, 157 < 18
years old
Yes/no 28% fatigue in children,
37% fatigue in adults.
81% of children
improve on GFD, 51%
of adults improve on
GFD
CeD PRO, celiac disease patient reported outcome; CFS-Q, chronic fatigue syndrome-questionnaire; D-FIS, daily fatigue impact scale; FIQ, fibromyal-
gia impact questionnaire; FSS, fatigue severity scale; fVAS, fatigue visual analog scale; GBB-24, Gieβener symptom check list; GFD, gluten-free diet;
GI, gastrointestinal; HCS, healthy control subjects; HR-QoL, health-related quality of life.
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significantly higher in celiac disease patients (mean 36.3 vs 16.7,
median 35 vs 15) than in HCS.20
Effect of a GFD on fatigue. Seven studies explored the
effect of GFD on fatigue.18,20,21,23,24,28,33 Five studies reported
less fatigue after the patients were on a GFD,18,23,24,28,33 but only
two of these studies used specific fatigue instruments, namely,
the D-FIS, fVAS, and FIQ.23,24 The median D-FIS score in
untreated patients was 16.0 versus 3.0 on the diet.23 After 1 year
on the GFD, the median D-FIS decreased from 13.0 to 7.0.23
The mean fVAS was reduced from 79 to 39 after introducing a
GFD, and the mean FIQ score was reduced from 74.3 to 36.6.24
In two other studies, there was no significant difference in fatigue
scores between patients on a GFD and patients on a regular diet.
Discussion
Fatigue in celiac disease has not been investigated much previ-
ously. However, clinical experiences, as well as previous case
reports, indicate that it may represent a significant problem for
these patients.46,47 In the current review, 18 studies addressing
fatigue in celiac disease were finally included, but only 4 studies
presented fatigue as a specific end-point.20,21,23,24 In the remain-
ing 14 studies, fatigue was registered as one of many possible
phenomena that patients with celiac disease may experience.
Thus, fatigue has not been the main focus of interest in the cur-
rently available literature.
The fatigue prevalence reported in previous studies is vari-
able, ranging from 8 to 100%. The only study presenting preva-
lence rates and using a fatigue-specific instrument (fVAS)
reported a fatigue prevalence of 100% before the GFD.24 In this
group of patients with both irritable bowel syndrome and fibro-
myalgia, along with associated celiac disease, the prevalence of
fatigue was probably overestimated. The other studies reporting
prevalence have registered and presented fatigue or tiredness
dichotomously with a yes/no response, and the definition of
fatigue is unclear. The prevalence at the time of diagnosis in
these studies ranged from 8 to 82%.25,32 As no validated fatigue
instrument or cut-off was used, and fatigue was not clearly
defined in most studies, these results should be interpreted with
caution. No fatigue prevalence data are available regarding
patients who are on a GFD.
In most previous studies, fatigue severity has been investi-
gated using a more specific approach, with selected fatigue
instruments to aid in the diagnosis. This is reflected in less vari-
ety in the reported data regarding fatigue severity than in fatigue
prevalence. However, only three studies applied the same fatigue
instrument and are directly comparable. Moreover, none of the
studies addressing fatigue severity defined a cut-off score for sig-
nificant fatigue. Fatigue severity was consistently higher in celiac
patients than in healthy controls.
A GFD is the only established treatment for celiac disease;
it leads to mucosal normalization or improvement in 65 to 100%
of patients and improves or eradicates symptoms.10 However,
data regarding the effect of GFD on fatigue are sparse. Previous
studies have reported that fatigue persists after GFD in some
patients.48,49 In the current review, the seven studies that regis-
tered fatigue before and after GFD demonstrated less fatigue after
commencing the GFD. One study reported higher fVAS scores
but lower FSS scores on the GFD, although these differences
were not significant.20 Two of the studies reporting fatigue before
and after GFD were not longitudinal,20,21 meaning that the
patients reporting fatigue after GFD are not the same as the
patients reporting fatigue at the time of diagnosis, and it is
unknown how the patients already on a GFD scored before they
commenced the diet. Three studies addressing change in fatigue
with GFD did not use validated fatigue scores; they just stated
that fatigue was reduced.18,28,33 Two studies evaluating the effect
of GFD on fatigue had very small sample sizes of 3 and
7 patients.23,24 Taken together, the limited amount of data sug-
gests that fatigue may improve with a GFD.
The fatigue experienced by patients is influenced by sev-
eral factors, including disturbed sleep, pain, and psychological
conditions, such as depression.2 Most of the studies included in
our review report fatigue as a dichotomous variable with a yes/no
response and did not evaluate fatigue in association with other
symptoms. One of the included studies looked at the quality of
sleep in patients with celiac disease, finding that reduced sleep
quality and sleep disorders are directly related to fatigue.21 One
study found that fatigue was correlated with depression in
untreated patients, but in patients on a GFD, depression persisted
or worsened as fatigue was reduced.20
A recent review that evaluated psychological morbidity in
celiac disease suggested that celiac disease has a considerable
psychological impact, related both to the disease itself and to the
patient’s subjective perception of the disorder and the GFD treat-
ment.50 Moreover, fatigue is often rated by patients with chronic
inflammatory diseases as one of the most important features lead-
ing to decreased quality of life.3 Celiac patients consistently
reported reduced quality of life compared to healthy controls in
previous studies. Furthermore, fatigue has been linked to unde-
tected celiac disease,16 and it is likely that fatigue contributes to
the reduced quality of life. One of the included studies looked at
the influence of fatigue on patients’ health-related quality of life
and found that fatigue is inversely proportional to health-related
quality of life.23
Measuring fatigue represents a challenge due to its non-
specific and subjective nature. The definition of fatigue among
celiac patients has varied in previous studies. Moreover, whether
different dimensions of fatigue exist, such as peripheral, physical,
mental, or central (general), or if fatigue only represents a unidi-
mensional trait is unclear. This makes it difficult to compare
fatigue prevalence and severity across different studies. Several
validated instruments are available to evaluate fatigue, but no
“gold standard” of fatigue measurement exists. Several scores
have been validated in chronic inflammatory conditions, such as
rheumatoid arthritis, systemic lupus erythematosus, and multiple
sclerosis, but have not yet been used or validated in celiac dis-
ease.36,41 Only four studies in our review applied validated
fatigue scores in celiac disease. Two studies presented a clear
definition of fatigue. Thus, the terminology for fatigue has been
variable, using different terms such as tiredness, fatigue, weak-
ness, and lethargy in the included articles. Consequently, it is dif-
ficult to ascertain if all studies have addressed the same subjects
and if the different terms have been equally understood by the
participants.
The variable study design of several previous studies ham-
pers their results. Data originate mostly from cross-sectional or
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retrospective studies instead of randomized controlled trials or
cohort studies. In many cases in which follow-up data were
included, the sample size has been small. Fatigue has not been
the primary end-point in most studies. Six of the prevalence stud-
ies are retrospective, including retrospective chart reviews and
mail studies. Retrospective mail or chart studies are less credible
than prospective controlled trials as they are less accurate and
subject to recall bias, and the diversity in results regarding preva-
lence may be due to differences in study design and limited
methodological quality.
In conclusion, previous studies indicate that fatigue is a
substantial complaint among patients with celiac disease. GFD
may improve fatigue, but data are limited. Previous studies are
difficult to interpret due to different study designs, inadequate
definitions of fatigue, and imperfect use of validated instruments
to measure fatigue. Thus, longitudinal studies using appropriate
fatigue instruments are warranted.
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